Viewing Study NCT06624592


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2025-12-24 @ 3:16 PM
Study NCT ID: NCT06624592
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2024-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000071257', 'term': 'Emergence Delirium'}], 'ancestors': [{'id': 'D003693', 'term': 'Delirium'}, {'id': 'D003221', 'term': 'Confusion'}, {'id': 'D019954', 'term': 'Neurobehavioral Manifestations'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D011183', 'term': 'Postoperative Complications'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D019965', 'term': 'Neurocognitive Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000077149', 'term': 'Sevoflurane'}, {'id': 'D007530', 'term': 'Isoflurane'}], 'ancestors': [{'id': 'D008738', 'term': 'Methyl Ethers'}, {'id': 'D004987', 'term': 'Ethers'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D006845', 'term': 'Hydrocarbons, Fluorinated'}, {'id': 'D006846', 'term': 'Hydrocarbons, Halogenated'}, {'id': 'D006838', 'term': 'Hydrocarbons'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 400}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2024-12-20', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-12', 'completionDateStruct': {'date': '2026-11-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-12-14', 'studyFirstSubmitDate': '2024-08-21', 'studyFirstSubmitQcDate': '2024-10-01', 'lastUpdatePostDateStruct': {'date': '2025-12-16', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2024-10-03', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-11-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of subjects with emergence delirium', 'timeFrame': 'Within 1 hour after dropped off by anesthesiology team', 'description': 'Total number of subjects with a Pediatric Anesthesia Emergence Delirium (PAED) score of \\> 10. The PAED scale consists of 5 criteria that are scored using a 5-point scale. The scores of each criterion are added to make a total score. The maximum achievable total score is 20.'}], 'secondaryOutcomes': [{'measure': 'Post Anesthesia Care Unit (PACU) length of stay', 'timeFrame': 'Post-procedural (0-4 hours after anesthesiology drop off)', 'description': 'Number of hours spent in PACU during recovery'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Delirium on Emergence']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD'], 'maximumAge': '7 Years', 'minimumAge': '2 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Pediatric patients aged 2-7 years.\n* Surgeries include ENT cases (i.e., tonsillectomy/adenoidectomy), ophthalmology cases (i.e., strabismus), and urology cases.\n* Can be outpatient or General Care inpatient procedures.\n* All cases must include an IV and an endotracheal tube (ETT).\n\nExclusion Criteria:\n\n* Severe developmental/cognitive delay (unable to make eye contact, nonverbal, or inability to interact with providers for PAED scale assessment requirements)\n* TIVA cases.\n* No PIV in place during the case, planned PICU admission postoperatively.\n* Previous history of severe emergence delirium documented by a provider (via interventions or explicitly stated).'}, 'identificationModule': {'nctId': 'NCT06624592', 'briefTitle': 'Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium', 'organization': {'class': 'OTHER', 'fullName': 'Mayo Clinic'}, 'officialTitle': 'Sevoflurane/Dexmedetomidine vs. Isoflurane and Their Effects on Pediatric Emergence Delirium', 'orgStudyIdInfo': {'id': '24-002252'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Isoflurane group', 'interventionNames': ['Drug: Isoflurane']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Sevoflurane group', 'interventionNames': ['Drug: Sevoflurane']}], 'interventions': [{'name': 'Sevoflurane', 'type': 'DRUG', 'description': 'Subjects will receive standard of care anesthesia Sevoflurane, with intravenous push Dexmedetomidine', 'armGroupLabels': ['Sevoflurane group']}, {'name': 'Isoflurane', 'type': 'DRUG', 'description': 'Subjects will receive standard of care anesthesia Isoflurane', 'armGroupLabels': ['Isoflurane group']}]}, 'contactsLocationsModule': {'locations': [{'zip': '55905', 'city': 'Rochester', 'state': 'Minnesota', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Lindsay Warner', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Mayo Clinic in Rochester', 'geoPoint': {'lat': 44.02163, 'lon': -92.4699}}], 'centralContacts': [{'name': 'Lindsay Warner, MD', 'role': 'CONTACT', 'email': 'warner.lindsay@mayo.edu', 'phone': '507-284-2511'}, {'name': 'Molly Herr, MD', 'role': 'CONTACT', 'email': 'herr.molly@mayo.edu', 'phone': '507-284-2511'}], 'overallOfficials': [{'name': 'Lindsay Warner, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Mayo Clinic'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Mayo Clinic', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Lindsay L. Warner', 'investigatorAffiliation': 'Mayo Clinic'}}}}